Cite
HARVARD Citation
Arribillaga, L. et al. (2020). Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens. Journal for immunotherapy of cancer. 8 (1), p. . [Online].